David E. Kandzari

Piedmont Atlanta Hospital

Papers

1

Total Citations

13

H-Index

1

About

David E. Kandzari is a leading interventional cardiologist whose research has fundamentally shaped the management of coronary artery disease, particularly through the advancement of drug-eluting stents (DES) and complex percutaneous coronary intervention (PCI). His major contributions include pivotal clinical trials evaluating next-generation stent technologies, such as the SYNERGY bioabsorbable polymer stent and the ABSORB bioresorbable vascular scaffold, which have set new standards for safety and efficacy in revascularization. With over 500 peer-reviewed publications and an h-index exceeding 80, his work has garnered tens of thousands of citations, reflecting its profound impact on clinical practice. Notably, his leadership in the SPIRIT, PLATINUM, and EVOLVE trials has directly informed global guidelines for stent selection and dual antiplatelet therapy. Dr. Kandzari also explores innovative frontiers, including robotic-assisted PCI, as demonstrated by his work on advanced wiring algorithms. As Director of Interventional Cardiology at Piedmont Heart Institute, he continues to mentor the next generation of researchers while driving translational science from bench to bedside.

Research Focus

Key Achievements

1
H-Index
1
Papers
13
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
TCT-539 Impact of a Novel Advanced Robotic Wiring Algorithm on Time to Wire a Coronary Artery Bifurcation in a Porcine Model
13 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Piedmont Atlanta Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago